A p.A300D missense mutation in the PTCH1 gene was previously reported in human neuroblastoma [12], suggesting that missense mutations could impair neuroblast differentiation and cooperate in MYCN driven tumor formation. This evidence concerns the gene MYCN and neuroblastoma.